ELKHART, Indiana, May 4, 2026 – Elkhart Clinic’s hematology and oncology practice has joined American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices. The practice, located at 2117 W. Lexington Ave., will now be known as Elkhart Hematology and Oncology.

This partnership enables Ahsanul Haque, MD, and Charisse Prall, NP, to expand patient-focused services, enhance access to clinical trials and pursue new growth opportunities while continuing to deliver the high-quality, compassionate care that has defined the practice since its founding.

Dr. Haque is a Board-certified medical oncologist and hematologist who earned his medical degree from Dow Medical College. He completed his residency and fellowship training in hematology and oncology at Maimonides Medical Center in Brooklyn, New York, where he developed expertise in both malignant and benign hematologic conditions, as well as solid tumor oncology.

Prall is a Board-certified family nurse practitioner who earned her Master of Science in nursing, with a family nurse practitioner specialty, from the University of Saint Francis. Her experience in oncology and hematology includes providing comprehensive care to patients with solid tumors, hematologic malignancies and nonmalignant hematologic conditions.

“We are pleased to join American Oncology Network,” said Dr. Haque. “The organization shares our commitment to delivering exceptional, research-based cancer care. This partnership strengthens our ability to support our patients as whole people – physically, emotionally, and financially. Together, we are well-positioned to provide a compassionate, patient-centered experience for every individual we serve.”

Elkhart Hematology and Oncology is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. The practice offers comprehensive cancer care, combining the expertise of a cancer specialty practice with the accessibility of care close to home. Services include onsite infusion therapy, centralized laboratory and pathology services, an in-house specialty pharmacy, comprehensive care coordination and dedicated financial counseling.

“We are thrilled to welcome Elkhart Hematology and Oncology to American Oncology Network,” said Todd Schonherz, chief executive officer of AON. “Dr. Haque and Charisse’s dedication to delivering exceptional, patient-centered care in Indiana aligns with AON’s mission to expand access to high-quality, community-based oncology services across the nation, and we couldn’t be happier that they’ve decided to join us.”

“Dr. Haque and Charisse have built an exceptional community oncology practice in Elkhart,” said Stephen “Fred” Divers, MD, chief medical officer of AON. “We are looking forward to partnering with them to continue delivering compassionate, patient-centered care in Indiana, and benefiting from their clinical expertise and commitment across the network.”

Dr. Haque is accepting new patients. To learn more about Elkhart Hematology and Oncology, visit elkharthemonc.com. For more information about American Oncology Network, visit AONcology.com.

About Elkhart Hematology and Oncology

Elkhart Hematology and Oncology is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, we strive to provide the best possible experience to patients and their families throughout the healthcare journey.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 350 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com more information, or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

The Maryland-area community oncology practice has developed one of the first outpatient, community-based T-cell-engaging programs, expanding access to advanced therapies, including bispecifics and CAR T-cell therapy.

BETHESDA, Md., Apr. 23, 2026 – The Center for Cancer and Blood Disorders (CCBD), a partner practice of American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, today announced it has launched a new program to deliver chimeric antigen receptor (CAR) T-cell therapy to patients in the Maryland area, including Washington, D.C., and Northern Virginia. 

The oncologist-led program significantly expands patient access to CAR T-cell therapy, a groundbreaking immunotherapy that uses the body’s immune system to fight cancer. The treatment modifies a patient’s own T cells to identify and destroy cancer cells and is primarily used for certain blood cancers, including lymphoma, leukemia, and multiple myeloma.

Ralph Boccia, MD, FACP, Board-certified oncologist and hematologist at CCBD and medical director of CCBD and research for AON, is leading the program. A nationally recognized leader in clinical research, Dr. Boccia completed transplant training at UCLA and established the first FACT-accredited transplant unit in the Maryland and Washington, D.C. region at Holy Cross Hospital. He has dedicated his career to bringing innovative therapies into community oncology settings and expanding cutting-edge care.

Dr. Boccia, along with Board-certified medical oncologist and hematologist Shreya Desai, MD, a member of the CCBD CAR T-cell team who recently joined the practice from the Medical College of Georgia, nurse practitioner Susan Granato, CRNP, and physician assistant, Josiane Tossa, PA-C, MPH, are now treating CCBD’s first CAR T-cell patient in the community setting, and continue to work with AON Research to treat patients on CAR-T and bispecific clinical trials.

As one of the first community oncology practices to offer CAR T-cell therapy outside of a hospital, CCBD’s program represents a significant milestone in expanding access to advanced cancer care closer to where patients live and work.

CCBD’s care delivery model includes close coordination between its physician-led clinic and local hospitals to ensure appropriate monitoring, patient safety and optimal outcomes.

“Treating patients with CAR T-cell therapy in a community oncology practice is an important step forward in our mission to provide every patient with access to the highest quality cancer care and the most advanced treatments available,” Dr. Boccia said. “By expanding access to CAR T-cell therapy through collaboration with our local community hospital, we are bringing innovative, life-saving treatments closer to home while helping reduce the burden of care for our patients.”

Prior to receiving formal authorization to administer T-cell redirecting therapies, including CAR T-cell therapy, CCBD had already treated patients through four outpatient CAR T-cell clinical trials and three outpatient bispecific trials. This early experience has positioned CCBD to be among the first community oncology practices in the country to offer these treatments in an all outpatient setting.

In his dual role as medical director of American Oncology Network Research, and as the leader of the CCBD research team, Dr. Boccia is dedicated to bringing T-cell therapy to oncology practices through innovative clinical research. AON’s research team helps advance trial activation, patient clinical trial enrollment and care coordination, ensuring that patients can access innovative therapies early while maintaining the highest standards of safety and quality, which will play an important role in the continued expansion of CAR T-cell access to practices throughout the AON network.

“Clinical research accelerates access to innovative therapies in the community setting, ensuring more patients can benefit from these advancements in an outpatient setting without needing to travel far from home,” said Katie Goodman, vice president of clinical research at AON. “The AON research team is looking forward to ongoing collaboration with Dr. Boccia and the CCBD team as AON continues to grow and expand access to CAR-T cell therapy in additional community oncology practices across its network.”

In Maryland, CAR T-cell therapy is generally covered by Medicare and many commercial insurance plans when deemed medically necessary for FDA-approved indications. Coverage typically requires prior authorization and treatment at accredited centers. As of Jan. 1, 2026, Maryland Medicaid provides access to certain FDA-approved cell and gene therapies through specialized access models, covering evaluation, infusion, and follow-up at approved centers.

State leaders also continue to prioritize access to innovative, personalized treatments. Recent legislative efforts, including expansion of “Right to Try” initiatives, support patients seeking customized therapies such as personalized CAR T-cell treatments. Additionally, utilization management policies in 2026 reflect a continued focus on supporting clinical trials and expanding the use of CAR T-cell therapy, including for emerging indications such as solid tumors.

About The Center for Cancer and Blood Disorders (CCBD)

Specialists in the diagnosis and treatment of blood disorders and cancer, The Center for Cancer and Blood Disorders has been serving patients in the communities and surrounding areas of Bethesda, Germantown, and Baltimore, Maryland for more than 25 years. Their individualized approach to patient care includes chemotherapy, targeted therapy, immunotherapy and when appropriate, cutting-edge therapies on clinical trials. The practice regularly performs more than 300 clinical trials on new and developing diagnostic devices and techniques for cancer and diseases. Patients receive home delivery of oral cancer medications, in-house lab and pathology and on-site infusion therapy. The practice also offers comprehensive support with nutrition guidance and financial counseling. Learn more at ccbdmd.com.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 350 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:

Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

AON leaders to speak on panels focused on advocacy, innovation and access in independent community oncology

FORT MYERS, Fla., April 21, 2026 – American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced it will participate in 12 speaking sessions at the 2026 Community Oncology Alliance (COA) Annual Conference. The event, themed Innovation in Practice, will take place April 28-29 in Orlando, Florida.

“At AON, we are committed to advancing community oncology through innovation that supports local practices and improves patient outcomes,” said Stephen “Fred” Divers, MD, AON’s chief medical officer, medical oncologist at Genesis Cancer and Blood Institute, and officer-at-large on COA’s Executive Committee. “The conference provides an important platform to share forward-thinking strategies, from new care delivery models to emerging therapies, that are transforming how care is delivered in community settings. I look forward to hearing AON thought leaders share insights with fellow community oncology colleagues.”

AON leaders will speak on a range of topics, including innovative therapies such as CAR T, the importance of high-quality data for smarter payer contracting, patient advocacy, clinical trials, radiopharmaceuticals, and careers in community oncology. Featured speakers include:

• Stephen “Fred” Divers, MD, AON chief medical officer, oncologist and hematologist at AON partner practice, Genesis Cancer and Blood Institute, and officer-at-large on COA’s Executive Committee – The Quality of Community Oncology: Presenting the COA Quality & Value Study
• Alti Rahman, MHA/MBA, CSSBB, AON chief strategy and innovation officer and COA board member – Better Data, Better Decisions: Leveraging Transparency for Smarter Contracting
• Ralph Boccia, MD, FACP, AON medical director of research and oncologist and hematologist at AON partner practice, The Center for Cancer and Blood Disorders – CAR T Comes to Main Street: Expanding Access, Empowering Care. Dr. Boccia will discuss how AON has developed one of the first outpatient community-based T-cell-engaging programs, featuring both outpatient bispecific therapies and CAR-T cell therapy, and how this approach is expanding access to advanced treatments within community clinics.
• Katie Alexander, MS, APRN-CNP, AOCNP, BBA, nurse practitioner at AON partner practice, The Zangmeister Cancer Center, and AON central region APP coordinator – The Value of Innovative Therapies for Patients
• Tyler Fugere, MD, oncologist and hematologist at AON partner practice, Genesis Cancer and Blood Institute – What I Wish I’d Known: First-Year Insights After Fellowship
• James Gilmore, PharmD, AON chief pharmacy and clinical services officer – Access & Affordability in the Era of Innovation: Cellular Therapies in Community Oncology
• Jim Chen, MD, oncologist and hematologist at AON partner practice, Genesis Cancer and Blood Institute – Community Oncology as a Career: Voices from the Frontlines
• Sunshine Maracle, AON national event and partnership manager and physician liaison at AON partner practice, Hope Cancer Care of Nevada – CPAN Advocates in Action
• Guy Messer, AS-NMT, BS-HCM, MBA, AON vice president of radiation and radiology services – Building an Innovative and Financially Sustainable Radiopharmaceutical Program
• Emily Whitman, MD, oncologist and hematologist at AON partner practice, Zangmeister Cancer Center – Multidisciplinary Physician Collaboration Driving Innovation in Community Oncology
• Julio Peguero, MD, medical director of research and oncologist at AON partner practice, Oncology Consultants – Expanding Clinical Trial Access in Community Oncology: Tech Tools and Support Strategies
• Brooke Peters, PharmD, BCOP, AON clinical pharmacist – Strengthening the Community Pharmacist’s Involvement in Operational Workflows for BsAb Therapy 
• Beau Hilton, MD, oncologist and hematologist at AON partner practice, Genesis Cancer and Blood Institute – Community Oncology as a Career: Voices from the Frontlines 

“AON and COA share a mission to protect and promote independent oncology, while embracing the innovation required to meet the evolving needs of patients,” said Alti Rahman, AON chief strategy and innovation officer and COA board member. “By bringing together leaders from across the country, this conference fosters collaboration and accelerates the adoption of data-driven insights, advanced technologies and new care models that are redefining what is possible in community oncology.”

AON provides comprehensive support services to independent oncology practices, including in-house pharmacy, lab services, revenue-diversifying programs and back-office operations. By partnering with AON, physicians can focus on delivering high-quality, patient-centered care in their communities without relying on hospital systems or third-party providers.

AON will also exhibit at booth 207 during the conference.

For more information about AON, visit AONcology.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 350 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

HOUSTON, Texas., March 4, 2026 – Oncology Consultants, a trusted provider of cancer care across South Texas, announced it has joined American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices.

This partnership allows Oncology Consultants to expand its patient-focused services, enhance clinical trial access and pursue new growth opportunities while continuing to deliver the high-quality, compassionate care the practice has provided since its founding in 1982.

“We are pleased to join American Oncology Network and align with an organization that shares our commitment to personalized, high-quality cancer care in the community,” said Luis T. Campos, MD, president of Oncology Consultants and a Board-certified medical oncologist. “This partnership strengthens our ability to bring advanced therapies and expanded services to our patients while maintaining the patient-centered approach that has long defined our practice. Together, we are well-positioned to improve access, convenience and outcomes for the communities we serve.”

“This partnership with American Oncology Network supports our ability to continue delivering high-quality, evidence-based care while expanding access to clinical trials, advanced therapies and operational resources,” said Alex P. Nguyen, MD, vice president of Oncology Consultants and a Board-certified medical oncologist and hematologist. “Most importantly, it allows our physicians to remain focused on what matters most – providing personalized, compassionate care to patients close to home.”

Oncology Consultants provides community-based oncology care at 18 locations across South Texas and is staffed by 16 Board-certified medical oncologists, 3 Board-certified radiation oncologists, and 23 advanced practitioners. The practice offers comprehensive services, including access to the latest cancer therapies, radiation services, diagnostic imaging, laboratory testing, pharmacy services, survivorship programs and patient support – all delivered close to home to help reduce travel burdens for patients and families. Clinics feature private exam rooms and on-site infusion suites designed to promote patient comfort and privacy.

“This partnership represents an important milestone for Oncology Consultants and the patients we serve,” said Rosa Fletcher, MBA, chief executive officer of Oncology Consultants. “Joining AON allows us to preserve our independence and culture while gaining access to resources, infrastructure and expertise that reduces administrative burden and supports long-term sustainability. Most importantly, it enhances our ability to deliver innovative, high-quality cancer care in the communities where patients live and work.”

“Joining American Oncology Network represents an important step forward for our practice and our patients,” said Yuval Raizen, MD, a Board-certified medical oncologist and hematologist and an Executive Committee member of Oncology Consultants. “This collaboration provides the scale, infrastructure and clinical resources needed to support innovation in cancer care while preserving the independence and physician-led decision-making that are essential to serving our patients effectively. We are excited about the opportunities this partnership creates for both our care teams and the communities we serve.”

“We are proud to welcome Oncology Consultants to American Oncology Network,” said Todd Schonherz, chief executive officer of AON. “Their longstanding reputation for exceptional, patient-centered care aligns seamlessly with AON’s mission to expand access to high-quality, community-based oncology services. This partnership reflects our shared commitment to individualized care and strengthens our presence in Texas while supporting collaboration with physician groups and local health systems.”

“Oncology Consultants has made a meaningful impact by delivering world-class cancer care in the community setting,” said Stephen “Fred” Divers, MD, chief medical officer of AON. “Their clinical expertise, dedication to patients and collaborative spirit will further enhance the care we provide across the network. We are excited to welcome the Oncology Consultants team and look forward to working together to advance community oncology.”

Oncology Consultants providers are now accepting new patients. To learn more about Oncology Consultants, visit oncologyconsultants.com. For more information about American Oncology Network, visit AONcology.com.

About Oncology Consultants

Oncology Consultants (OC) is the largest independent community oncology practice in Houston. Since 1982, it has been committed to delivering cutting-edge cancer treatment in a caring environment. With locations throughout South Texas, Oncology Consultants offer a comprehensive range of services and treatments, including infusion therapy, radiotherapy, diagnostic imaging, pharmacy services, clinical trials, genetic testing, telemedicine, and more.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 350 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com more information, or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Board-certified medical oncologist and hematologist Ravikumar Vasireddy, MD, has cared for patients in the Muskogee community for more than 20 years.

MUSKOGEE, Okla., Feb. 3, 2026 – RKV Medical Center (RKV), a trusted provider of cancer and blood disorder care in Muskogee and surrounding communities, today announced it has joined American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, becoming the network’s first partner practice in Oklahoma. The practice is located at 301 N. 32nd St. in Muskogee. Dr. Ravikumar Vasireddy is accepting new patients and can be reached at 918-683-2000.

The partnership allows RKV Medical Center to expand patient-focused services, increase access to clinical trials and advanced therapies, and pursue future growth opportunities while continuing to deliver the high-quality, compassionate care that has defined the practice for more than two decades.

RKV Medical Center is led by Ravikumar Vasireddy, MD, a Board-certified medical oncologist and hematologist who has proudly served patients in the Muskogee community for more than 20 years. As a community oncology practice, RKV provides comprehensive cancer care in a local, outpatient setting, bringing personalized, research-based treatment closer to home.

“At RKV Medical Center, our priority has always been to care for the whole person, not just the disease,” Vasireddy said. “Joining American Oncology Network allows us to strengthen that commitment by expanding access to advanced treatments and resources while preserving the personalized, community-based approach our patients know and trust.”

RKV Medical Center offers a comprehensive range of services designed to support patients physically, emotionally and financially throughout their cancer journey. Services include onsite infusion therapy, including immunotherapy; centralized laboratory and pathology services with faster turnaround times; an in-house specialty pharmacy for timely delivery of oral cancer medications; comprehensive care coordination for symptom management, nutrition and overall well-being; and dedicated financial counseling to help patients navigate coverage and access available assistance programs. RKV also offers diagnostic imaging and radiation oncology services.

By combining specialty expertise with care delivered close to home, RKV Medical Center remains committed to providing a compassionate, patient-centered experience for every individual it serves.

Vasireddy earned his medical degree from Kakatiya University in Warangal, India, where he also completed a residency in pathology. He later completed a dermatology residency at Osmania University in Hyderabad, India, followed by an internal medicine residency at Prince George’s Hospital in Cheverly, Maryland. He completed his fellowship in medical oncology and hematology at the University of Cincinnati in Ohio. Vasireddy is certified by the American Board of Internal Medicine and licensed by the Oklahoma State Medical Board. His clinical interests include lung cancer, breast cancer, multiple myeloma, lymphoma and colon cancer.

“We are pleased to welcome RKV Medical Center to American Oncology Network,” said Todd Schonherz, chief executive officer of AON. “Dr. Vasireddy’s longstanding dedication to delivering high-quality, personalized cancer care in the community strongly aligns with AON’s mission. This partnership enhances our presence in Oklahoma and reinforces our commitment to increasing access to community-based oncology care.”

“Dr. Vasireddy has built a respected practice centered on clinical excellence and patient trust,” said Stephen “Fred” Divers, MD, chief medical officer of AON. “His expertise and collaborative approach will be a valuable addition to our network as we continue advancing high-quality community oncology care.”

For more information about American Oncology Network, visit AONcology.com. To learn more about RKV Medical Center, visit rkvmedicalcenter.com.

About RKV Medical Center
RKV Medical Center is a community-based medical oncology and hematology practice serving Muskogee, Oklahoma, and surrounding areas for more than 20 years. The practice specializes in the diagnosis and treatment of cancer and blood disorders and is dedicated to providing compassionate, patient-centered care throughout every stage of the healthcare journey. For more information, please visit rkvmedicalcenter.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com